$CNTA Centessa Pharmaceuticals plc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Centessa Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Centessa Pharmaceuticals plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Centessa Pharmaceuticals plc for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CNTA
Company Address: THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE CB22 3FH
Former name: Centessa Pharmaceuticals Ltd, date of change: 2021-02-24
Centessa Pharmaceuticals plc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Option Exercise | C | 0.00 | 44,828 | 0 | 0 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Option Exercise | C | 0.00 | 1,886,990 | 0 | 0 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Option Exercise | A | 0.00 | 44,828 | 0 | 44,828 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Option Exercise | A | 0.00 | 1,886,990 | 0 | 1,886,990 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Buy | P | 20.00 | 13,923 | 278,460 | 88,887 | 75 K to 88.9 K (+18.57 %) |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Buy | P | 20.00 | 586,077 | 11,721,540 | 3,741,609 | 3.2 M to 3.7 M (+18.57 %) |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Buy | C | 0.00 | 44,828 | 0 | 74,964 | 30.1 K to 75 K (+148.75 %) |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | De Rubertis Francesco | Director | Buy | C | 0.00 | 1,886,990 | 0 | 3,155,532 | 1.3 M to 3.2 M (+148.75 %) |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | Bush Tia L | Chief Quality Offic ... | Option Exercise | A | 9.42 | 500,338 | 4,713,184 | 500,338 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | Bush Tia L | Chief Quality Offic ... | Buy | P | 20.00 | 3,000 | 60,000 | 3,000 | 0 to 3 K |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | GOYAL ARJUN | Director | Option Exercise | C | 0.00 | 85,909 | 0 | 0 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | GOYAL ARJUN | Director | Option Exercise | C | 0.00 | 3,095,909 | 0 | 0 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | GOYAL ARJUN | Director | Option Exercise | A | 0.00 | 85,909 | 0 | 85,909 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | GOYAL ARJUN | Director | Option Exercise | A | 0.00 | 3,095,909 | 0 | 3,095,909 | |
| Jun 04 2021 | CNTA | Centessa Pharmaceu ... | GOYAL ARJUN | Director | Buy | P | 20.00 | 20,250 | 405,000 | 106,159 | 85.9 K to 106.2 K (+23.57 %) |